This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Long-Term Safety Study of ALKS 5461
Clinical trial

A Long-Term Safety Study of ALKS 5461

Read time: 1 mins
Last updated:1st May 2014

This is a 52-week open-label study to evaluate the safety and tolerability of ALKS 5461.

Study Type: Interventional
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Estimated Enrollment: 1500
Study Start Date: May 2014
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)

- Experimental:
ALKS 5461

Category Value
Study start date 2014-05-01

View full details